Home LiteratureArticle Details
PMID: 164144 Published · ppublish English Journal Article

Primary meningococcal pneumonia.

Annals of internal medicine ·Vol. 82 ·No. 4 ·1975-04-00 ·Pages 493-8

Irwin RS, Woelk WK, Coudon WL

Abstract

Three cases of pneumonia caused by Neisseria meningitidis group Y are reported. From the results of these cases, the following conclusions were made. N. meningitidis probably can cause serious infection without preceding blood stream invasion. Primary meningococcal pneumonia is not rare; it has no distinctive clinical presentation; and it may not be recognized by routine expectorated sputum cultures. In addition, it may be associated with recent influenzal and adenoviral infections. Lastly, meningococci of the serogroup Y are capable of causing serious disease. Antimicrobial susceptibility studies showed that all three group Y isolates were sensitive to sulfadiazine and rifampin as well as to penicillin, ampicillin, erythromycin, and chloramphenicol.

MeSH Terms
Adenoviridae Infections/complications Adolescent Adult Female Humans Influenza, Human/complications Male Meningococcal Infections/diagnostic imaging,drug therapy Microbial Sensitivity Tests Neisseria meningitidis/isolation & purification Penicillin G Procaine/therapeutic use Penicillin Resistance Pneumonia/diagnostic imaging,drug therapy,etiology Radiography Tetracycline/therapeutic use
Chemicals
Penicillin G Procaine Tetracycline
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Irwin R S
Woelk W K
Coudon W L
Article Info
Journal
Annals of internal medicine
Abbr.
Ann Intern Med
ISSN
0003-4819
Published
1975-04-00
Pages
493-8
Language
English
Region
United States
NLM ID
0372351
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com